Comtech Telecommunications Corp. — Q2 FY2022 Form 10-Q
Reporting period: Three and six months ended January 31, 2022. The interim financial statements are unaudited. Comtech provides satellite communications, public safety and location technologies through its Commercial Solutions and Government Solutions segments.
Financial performance and liquidity
| Metric | Q2 FY2022 | Six months FY2022 |
|---|---|---|
| Net sales | $120.4 million; down 25.4% year over year | $237.1 million; down 20.0% |
| Gross profit / margin | $45.9 million / 38.1%, versus 34.5% | $87.6 million / 36.9%, versus 35.7% |
| Operating income (loss) | $(24.6) million, versus $5.4 million | $(31.1) million, versus $(80.3) million |
| Net income (loss) attributable to common stockholders | $(23.5) million; diluted EPS $(0.89) | $(34.7) million; diluted EPS $(1.31) |
| Adjusted EBITDA (non-GAAP) | $9.8 million, versus $18.1 million | $15.3 million, versus $32.3 million |
| Operating cash flow | Not separately stated in the financial statements for the quarter | $9.6 million provided, versus $63.4 million used |
Q2 gross margin improved partly due to favorable mix and a $2.5 million warranty-accrual benefit. Six-month operating cash flow included working-capital movements; the prior-year comparison was heavily affected by a $70.0 million payment to terminate the Gilat transaction. Investing cash outflow was $8.8 million and financing cash outflow was $0.7 million for the six months.
At January 31, cash was $30.9 million; current assets were $281.4 million and current liabilities $219.5 million. Credit Facility borrowings were $114.5 million, down from $201.0 million at July 31, 2021, and mature October 31, 2023. The company reported a 1.95x secured leverage ratio and 11.91x interest coverage, within covenant limits. The $100 million Series A preferred issuance added financing but carries a cumulative 6.5% annual dividend and senior rights.
Backlog was $611.1 million, down from $628.5 million at October 31, 2021; management reported approximately $1.2 billion of revenue visibility, including expected orders under certain multi-year contracts.
Material changes versus prior comparable periods
- Sales declined in both segments. Q2 Commercial Solutions revenue fell 7.4% to $81.3 million; Government Solutions fell 46.8% to $39.1 million. For the six months, the declines were 5.5% and 39.4%, respectively.
- Lower Government Solutions sales reflected reduced U.S. Army programs and the absence of prior-year sales under a Marine Corps troposcatter contract. Commercial Solutions was affected by weaker satellite ground-station demand, while public safety and location technology sales increased.
- Q2 GAAP results included $13.6 million of CEO transition costs and $9.1 million of proxy solicitation costs. Six-month proxy costs were $11.2 million. These unusual expenses contributed to the operating loss; excluding identified items, management calculated Q2 operating income of $0.1 million and six-month operating loss of $2.8 million.
- Prior-year six-month operating results included $94.5 million of acquisition-plan expenses, primarily related to the terminated Gilat merger and litigation. Thus, the smaller reported operating loss year over year does not indicate improved underlying performance; management cited lower sales as a key driver of adjusted results.
Outlook, commentary and risks
Management reduced FY2022 targets to approximately $520 million in net sales and $50 million in Adjusted EBITDA, from prior targets of $580–$600 million in sales and $70–$76 million in Adjusted EBITDA. It expected the second half to improve over the first half, with Q4 the strongest quarter, but did not provide GAAP guidance or a reconciliation to the non-GAAP target, citing unpredictable costs and items that could not be estimated without unreasonable effort.
- Russia’s invasion of Ukraine disrupted expected satellite and troposcatter orders and shifted defense spending priorities. Management assumed no further Russia sales in FY2022, estimating roughly $5 million of reduced order flow, and disclosed about $1.5 million of Russia exposure, primarily cash and receivables. Timing and value of expected Ukraine awards became unpredictable.
- Supply-chain shortages, component quality problems, longer lead times, inflation and freight costs may delay shipments and pressure costs and margins. Some components have single or limited sources, and replacement suppliers may not be available in time.
- COVID-19 effects, changing government funding and procurement, Afghanistan-related program changes, and the timing of large contracts make quarterly results volatile. U.S. government contracts may be terminated for convenience; IDIQ contracts do not guarantee purchases.
- Planned FY2022 capital spending was approximately $30 million, including NG-911 infrastructure and new manufacturing facilities in Arizona and the UK. The company had spent $8.8 million in the first half.
- The Series A preferred shares have conversion, voting and potential redemption rights; holders may require repurchase in specified circumstances, including after October 2026 or upon a change of control. Preferred dividends compound if paid in kind and may constrain common dividends.
- Other matters include customer indemnification claims, including potential 911-routing claims; the company says insurance may not cover all costs. A preferred-stock-related lawsuit was settled on specified terms, though certain obligations could lead to further litigation. Management did not expect other pending or threatened matters to have a material adverse effect.
Investor verification priorities
- Track whether sales, bookings and backlog convert into revenue, especially Government Solutions orders and anticipated Q4 awards; Q2 book-to-bill was 0.86x.
- Assess the revised $520 million sales and $50 million Adjusted EBITDA targets against supply availability, Ukraine-related delays and the company’s Q3/Q4 shipment assumptions.
- Review cash generation, working capital and planned capital expenditures alongside $114.5 million of secured debt, its October 2023 maturity and covenant headroom.
- Evaluate the full cost and dilution, dividend burden and governance or redemption provisions of the preferred stock; confirm whether the investors exercise the additional $25 million purchase option.
- Distinguish GAAP performance from Adjusted EBITDA and management’s exclusions; verify the size and timing of CEO-transition, proxy, restructuring and start-up costs.
- Monitor major customer concentrations, warranty estimates, potential indemnification exposure and goodwill impairment assumptions. The filing reported no goodwill impairment at the latest assessment.